Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Davidson

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of the American College of Nutrition|August 17, 2001
Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and womenM H Davidson, K C Maki, D M Umporowicz, et al.
Pharmacoeconomics|June 6, 1998
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatinM J Koren, D G Smith, D B Hunninghake, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humansJ I Schwartz, C C Chan, S Mukhopadhyay, et al.
The American Journal of Cardiology|July 29, 2000
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levelsJ J Kastelein, J L Isaacsohn, L Ose, et al.
The American Journal of Clinical Nutrition|July 14, 2001
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I dietK C Maki, M H Davidson, D M Umporowicz, et al.
The American Journal of Cardiology|January 1, 1997
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/dayM H Davidson, E A Stein, C A Dujovne, et al.
Clinical Cardiology|February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study GroupL Ose, M H Davidson, E A Stein, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 24, 2001
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemiaM H Davidson, E A Stein, D B Hunninghake, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of the American College of Nutrition|August 17, 2001
Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and womenM H Davidson, K C Maki, D M Umporowicz, et al.
Pharmacoeconomics|June 6, 1998
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatinM J Koren, D G Smith, D B Hunninghake, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humansJ I Schwartz, C C Chan, S Mukhopadhyay, et al.
The American Journal of Cardiology|July 29, 2000
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levelsJ J Kastelein, J L Isaacsohn, L Ose, et al.
The American Journal of Clinical Nutrition|July 14, 2001
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I dietK C Maki, M H Davidson, D M Umporowicz, et al.
The American Journal of Cardiology|January 1, 1997
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/dayM H Davidson, E A Stein, C A Dujovne, et al.
Clinical Cardiology|February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study GroupL Ose, M H Davidson, E A Stein, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 24, 2001
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemiaM H Davidson, E A Stein, D B Hunninghake, et al.
Pageof 7